2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid TumorsAdvanced Solid TumorActive, not recruitingPhase 1 / Phase 22026-02-02NCT05744427
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 32025-07-20NCT06464991